Sign up to save your podcasts
Or
Share Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44
Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.
Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.
It has become an iconic name in the field of artificial intelligence for drug discovery.
TPM E44 highlights >
Episode 44 links:
- Najat Khan on LinkedIn
- Recursion
View all episodes
By Genialis
4.7
77 ratings
Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.
Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.
It has become an iconic name in the field of artificial intelligence for drug discovery.
TPM E44 highlights >
Episode 44 links:
- Najat Khan on LinkedIn
- Recursion
More shows like Talking Precision Medicine
View all
Science Weekly
419 Listeners
Hidden Brain
43,448 Listeners
Pivot
9,291 Listeners
The Daily
110,877 Listeners
The Readout Loud
316 Listeners
Biotech 2050 Podcast
61 Listeners
The Prof G Pod with Scott Galloway
5,416 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,244 Listeners
BioCentury This Week
30 Listeners
Prof G Markets
1,195 Listeners